Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sunniva Inc C.SNN

Alternate Symbol(s):  SNNVF

Healthcare Biotechnology Cannabis
Sunniva Inc. is a Canada-based company. The Company is not engaged in any business.


CSE:SNN - Post by User

Sunniva Inc > Full Canaccord Coverage of Sunniva (51 Pages) - $13 Target
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(34)
•••
Comment by LifeGoesOn1973on Jul 03, 2018 12:44pm
58 Views
Post# 28262782

RE:RE:RE:RE:RE:RE:Full Canaccord Coverage of Sunniva (51 Pages) - $13 Target

RE:RE:RE:RE:RE:RE:Full Canaccord Coverage of Sunniva (51 Pages) - $13 Target
I think it perfectly makes sense. they are trying to force the price down so they can get shares at cheap prices
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities